Eubiologics to Co-Develop Nipah Virus Vaccine with KDCA

[NA Eun-kyung, Edaily Reporter] Eubiologics said Thursday it is jointly conducting a project with the National Institute of Health under the Korea Disease Control and Prevention Agency (KDCA) to develop a nanoparticle adjuvant based vaccine candidate to prevent Nipah virus infection.

The project is part of a government program to build rapid development technologies for priority infectious diseases that could trigger future pandemics.

The research aims to establish a national level response framework for high risk infectious diseases with pandemic potential.